Cancer involves abnormal cells growing uncontrollably, invading nearby tissues, and spreading to other parts of the body through metastasis.
Send us all your questions or requests, and our expert team will assist you.
The management of testicular cancer extends into a distinct phase of survivorship that focuses on long-term surveillance, hormonal health, and fertility restoration. Because the majority of patients are cured at a young age, they face decades of life ahead, making the management of “late effects” a critical component of care. Maintenance is not passive; it is an active, risk-adapted program designed to detect recurrence (which typically occurs within the first two years) and to mitigate the physiological cost of the curative therapies received.
Surveillance protocols are rigorous. For Stage I patients on active surveillance, the schedule typically includes physical exams, tumor markers, and abdominal CT scans or MRIs every 3 to 6 months for the first 2 years, then annually up to year 5. This intensity allows for the detection of relapse at a low volume when it can still be cured with standard chemotherapy. For patients who have received chemotherapy or radiation, surveillance also monitors for secondary malignancies (such as leukemia or solid tumors within the radiation field) and cardiovascular disease, which are elevated in this population.
The loss of a testicle (orchiectomy) and the toxic effects of chemotherapy can compromise Leydig cell function, leading to hypogonadism (low testosterone). Symptoms include fatigue, loss of libido, erectile dysfunction, metabolic syndrome, and osteoporosis. Maintenance care involves monitoring serum testosterone, LH, and FSH levels. Testosterone Replacement Therapy (TRT) is indicated for patients with symptomatic hypogonadism to restore quality of life, bone density, and metabolic health. However, TRT suppresses spermatogenesis, so fertility planning must be addressed before initiation.
For survivors who banked sperm before treatment, assisted reproductive technologies (ART) such as Intrauterine Insemination (IUI) or In Vitro Fertilization (IVF) offer a path to biological parenthood. For those who did not bank sperm or have azoospermia, recovery of spermatogenesis may occur months to years after chemotherapy. Maintenance care involves periodic semen analysis to assess recovery. In cases of persistent azoospermia, micro-dissection testicular sperm extraction (micro-TESE) from the remaining testicle may be an option to retrieve sperm for IVF.
Managing Late Effects of Therapy
The diagnosis of testicular cancer strikes at the core of male identity, body image, and sexuality. The loss of a testicle, hair loss from chemotherapy, and scars from surgery can lead to significant psychological distress, anxiety, and depression. “Scanxiety” (fear of recurrence before check-ups) is prevalent. Maintenance care integrates psychosocial support, including counseling and support groups. Prosthetic testicles (saline implants) can be placed at the time of orchiectomy or later to restore scrotal symmetry and improve body image, helping patients regain confidence.
Regenerative medicine plays a role in restoring the structural sequelae of treatment. Research into stem cell therapy for restoring Leydig cell function or spermatogenesis is ongoing. In the interim, optimizing the “physiome” through lifestyle medicine—regular exercise, heart-healthy diet, and smoking cessation—is the most effective way to counteract the metabolic risks associated with survivorship.
Quality of Life Metrics
The future of surveillance lies in “liquid biopsy.” The microRNA cluster miR-371a-3p has shown superior sensitivity and specificity compared to traditional markers (AFP/hCG) for detecting germ cell tumors. Its integration into clinical practice promises to reduce reliance on serial CT scans (sparing radiation exposure) and to enable earlier detection of recurrence. This molecular monitoring represents a shift towards a more precise, biologically driven survivorship plan.
Send us all your questions or requests, and our expert team will assist you.
A testicular prosthesis is a silicone- or saline-filled implant shaped and sized to look and feel like a natural testicle. It is surgically placed in the scrotum, either at the time of the cancer surgery or at a later date, to restore the cosmetic appearance of the scrotum. It has no hormonal or reproductive function; its purpose is purely aesthetic and psychological.
Yes, a single healthy testicle is usually sufficient to produce normal amounts of testosterone and sperm for natural conception. However, because cancer treatment (chemotherapy/radiation) can damage sperm production, and because the remaining testicle may have some underlying dysfunction, sperm banking before treatment is strongly recommended to ensure future fertility.
Surveillance typically lasts for 5 to 10 years. The intensity is highest in the first 2 years when recurrence is most likely. Visits and scans become less frequent (e.g., every 6-12 months) in years 3-5. After 5 years, most patients are considered cured, but annual check-ups are often advised to monitor for late side effects and general health.
Retrograde ejaculation is a side effect of RPLND surgery, where damage to the sympathetic nerves causes the bladder neck to stay open during orgasm. As a result, semen goes backward into the bladder instead of out through the penis. It causes “dry” orgasms. It is not harmful to health but causes infertility, which is why nerve-sparing techniques are used.
Numbness and tingling in the extremities (peripheral neuropathy) are common side effects of Cisplatin chemotherapy. It is caused by damage to the peripheral nerves. While it often improves after chemotherapy ends, some degree of numbness can be permanent. Medications and avoiding cold exposure can help manage the symptoms.
Leave your phone number and our medical team will call you back to discuss your healthcare needs and answer all your questions.
Your Comparison List (you must select at least 2 packages)
